Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
warfarin 5mg
DRUG
3 trials
Sponsors
Boehringer Ingelheim
Conditions
Atrial Fibrillation
Heart Valve Diseases
Heart Valve Prosthesis
Percutaneous Coronary Intervention
Thromboembolism
Phase 2
Dabigatran Etexilate in Patients With Mechanical Heart Valves
Terminated
NCT01452347
Boehringer Ingelheim
Heart Valve Diseases
Start: 2011-10-31
End: 2013-06-30
Updated: 2014-08-06
Follow on Study From RE-ALIGN
Terminated
NCT01505881
Boehringer Ingelheim
Heart Valve Prosthesis, Thromboembolism
Start: 2011-12-31
End: 2013-06-30
Updated: 2014-07-11
Phase 3
Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
Completed
NCT02164864
Boehringer Ingelheim
Atrial Fibrillation, Percutaneous Coronary Intervention
Start: 2014-07-22
End: 2017-06-05
Updated: 2018-07-31
Related Papers
Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial
Drugs
2020-06-19
17 citations
Comparison of Dabigatran Plus a P2Y<sub>12</sub> Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI.
2020-05-07
5 citations
Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention
Circulation Cardiovascular Interventions
2020-04-01
24 citations
P34 The effect of sex on the efficacy and safety of dabigatran dual therapy in atrial fibrillation after PCI: a subgroup analysis from the RE-DUAL PCI trial
European Heart Journal
2020-01-01
Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI.
2019-08-01
9 citations
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
New England Journal of Medicine
2017-08-27
1323 citations
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
New England Journal of Medicine
2013-09-01
1480 citations